NCT02791165

Brief Summary

There is an optimal day on which to perform the CMR scan which allows one to capture the information required to assess the dynamic changes in the reperfused STEMI patient. The main objective is to characterise the dynamic changes in LV function, MI size, myocardial edema, MVO, IMH, interstitial volume in the remote myocardium over the first 10 days of an acute reperfused STEMI in order to identify the optimal day for performing the CMR scan.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
20

participants targeted

Target at below P25 for all trials

Timeline
Completed

Started Dec 2015

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

December 1, 2015

Completed
6 months until next milestone

First Submitted

Initial submission to the registry

May 31, 2016

Completed
6 days until next milestone

First Posted

Study publicly available on registry

June 6, 2016

Completed
7 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 1, 2017

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

January 1, 2017

Completed
Last Updated

June 6, 2016

Status Verified

May 1, 2016

Enrollment Period

1.1 years

First QC Date

May 31, 2016

Last Update Submit

May 31, 2016

Conditions

STEMI

Outcome Measures

Primary Outcomes (1)

  • All cause mortality

    One year

Eligibility Criteria

Age21 Years - 99 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Patients presenting with an acute STEMI

You may qualify if:

  • Confirmed STEMI as per PPCI procedure reports/ clinical notes
  • Proximal to mid coronary artery occlusion.
  • Ability to provide informed consent

You may not qualify if:

  • Previous myocardial infarction or coronary artery bypass graft surgery
  • Contraindication for CMR (e.g. ferromagnetic implants, claustrophobia, estimated glomerular filtration rate \<30mL/min)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

National Heart Centre Singapore

Singapore, Singapore, 169609, Singapore

RECRUITING

Biospecimen

Retention: SAMPLES WITH DNA

Blood samples will be collected from all participants.

MeSH Terms

Conditions

ST Elevation Myocardial Infarction

Condition Hierarchy (Ancestors)

Myocardial InfarctionMyocardial IschemiaHeart DiseasesCardiovascular DiseasesVascular DiseasesInfarctionIschemiaPathologic ProcessesPathological Conditions, Signs and SymptomsNecrosis

Study Officials

  • National Heart Centre Singapore

    National Heart Centre Singapore

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Mung Peng

CONTACT

6704wong.mung.peng@nhcs.com.sg

Study Design

Study Type
observational
Observational Model
CASE ONLY
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

May 31, 2016

First Posted

June 6, 2016

Study Start

December 1, 2015

Primary Completion

January 1, 2017

Study Completion

January 1, 2017

Last Updated

June 6, 2016

Record last verified: 2016-05

Data Sharing

IPD Sharing
Will not share

Locations

SG(1)